CIK 0001676725
- Large accelerated filer
IDEAYA Biosciences, Inc.
Sign in to watch- Ticker
- IDYA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474268251
- Phone
- +1 650-443-6209
- Business address
- 5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $985,397
- in 1 filing, $985K under 10b5-1 plans
Net −$985,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-07-26 | Hager Jeffrey SVP, Chief Technology Officer | Exercise or conversion | +5,197 | $4.31 | $22K | 127,853 |
| 2019-07-26 | Hager Jeffrey SVP, Chief Technology Officer | Exercise or conversion · Stock Option (right to buy) | −5,197 | 10,396 | ||
| 2019-07-10 | Hager Jeffrey SVP, Chief Technology Officer | Exercise or conversion | +7,145 | $4.31 | $31K | 122,656 |
| 2019-07-10 | Hager Jeffrey SVP, Chief Technology Officer | Exercise or conversion · Stock Option (right to buy) | −7,145 | 33,275 | ||
| 2019-06-19 | Hager Jeffrey SVP, Chief Technology Officer | Exercise or conversion | +8,628 | $4.31 | $37K | 115,511 |
| 2019-06-19 | Hager Jeffrey SVP, Chief Technology Officer | Exercise or conversion · Stock Option (right to buy) | −8,628 | 40,420 |
Page 1 of 1 · 6 trades